Clinical Trials Arena March 8, 2024
GlobalData Healthcare

The US joins more than 100 countries where the contraceptive pill is available without a prescription.

Manufacturer Perrigo announced on 4 March that Opill (norgestrel), the first daily over-the-counter birth control pill, will be available in the US in the next few weeks.

Opill has been available by prescription for nearly 50 years, but last year, the Food and Drug Administration (FDA) approved Opill as a non-prescription oral contraceptive in the US. The cost of a one-month supply will be $19.99.

Opill is a progestin-only birth control pill, which is considered safer compared to other contraceptive drugs containing estrogen and progestin. Opill works by raising progestin levels, which leads to the thickening of the mucus in the cervix, preventing sperm...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
Drugmakers prep for bird flu outbreak, despite continued low risk
Heart health differences in men and women: Tiny RNA molecules play key role, study finds
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science
Healthcare supply chain, pharmacy costs to rise in 2025: report

Share This Article